Alinia (Nitazoxanide) - Summary

ALINIA SUMMARY

Alinia Tablets and Alinia for Oral Suspension contain the active ingredient, nitazoxanide, a synthetic antiprotozoal agent for oral administration. Nitazoxanide is a light yellow crystalline powder. It is poorly soluble in ethanol and practically insoluble in water.

Alinia for Oral Suspension (patients 1 year of age and older) and Alinia Tablets (patients 12 years and older) are indicated for the treatment of diarrhea caused by Giardia lamblia.

Alinia for Oral Suspension is indicated for patients 1 through 11 years of age for the treatment of diarrhea caused by Cryptosporidium parvum.

Alinia for Oral Suspension and Alinia Tablets have not been shown to be superior to placebo for the treatment of diarrhea caused by Cryptosporidium parvum in HIV-infected or immunodeficient patients (see CLINICAL STUDIES).

The safety and effectiveness of Alinia for Oral Suspension or Alinia Tablets for the treatment of diarrhea caused by Cryptosporidium parvum in patients 12 years of age and older have not been established.

See all Alinia indications & dosage >>

ALINIA NEWS HIGHLIGHTS

Media Articles Related to Alinia (Nitazoxanide)

August 2004
Source: Medscape Primary Care Headlines [2004.08.18]

more >>

Published Studies Related to Alinia (Nitazoxanide)

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4. [2008.09.01]

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4. [2008.06.26]

Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. [2006.11.15]

Nitazoxanide for the treatment of Clostridium difficile colitis. [2006.08.15]

Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. [2006.07.08]

more >>

Clinical Trials Related to Alinia (Nitazoxanide)

Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C [Active, not recruiting]

Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus [Completed]

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients [Recruiting]

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children [Completed]

A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis [Active, not recruiting]

more >>